Table 2.
HbA1c responders: clinical characteristics.
| Measures | All randomized at baseline | Responders at the 19-month follow-up | |||
|
|
Intervention mean (SD)a |
Control mean (SD) |
Intervention mean (SD) |
Control mean (SD) |
|
| HbA1cb in mmol/mol | 65.8 (11.8) | 63.6 (10.0) | 64.5 (15.8) | 64.6 (14.8) | |
|
|
Missing | 0 | 0 | 0 | 0 |
| HbA1c in % | 8.2 (11) | 8.0 (0.9) | 8.0 (1.4) | 8.1 (1.4) | |
|
|
Missing | 0 | 0 | 0 | 0 |
| BMIc in kg/m2 | 31.4 (4.9) | 30.2 (4.4) | 31.1 (4.6) | 29.8 (4.6) | |
|
|
Missing | 0 | 0 | 0 | 1 |
| Blood pressure in mm Hg |
|
|
|
|
|
|
|
Diastolic | 146 (19) | 145 (17) | 143 (24) | 144 (18) |
|
|
Systolic | 83 (10) | 81 (11) | 85 (12) | 82 (8) |
|
|
Missing | 0 | 0 | 0 | 0 |
| Lipids |
|
|
|
|
|
|
|
S-cholesterold | 5.29 (1.04) | 5.35 (1.38) | 5.18 (1.11) | 5.21 (1.14) |
|
|
Missing | 0 | 0 | 0 | 0 |
|
|
Triglycerides | 2.09 (1.23) | 2.35 (1.75) | 1.99 (0.98) | 2.13 (1.25) |
|
|
Missing | 0 | 0 | 0 | 0 |
|
|
HDLe | 1.23 (0.27) | 1.26 (0.32) | 1.22 (0.24) | 1.29 (0.31) |
|
|
Missing | 0 | 0 | 0 | 0 |
|
|
LDLf | 3.15 (0.86) | 3.05 (1.19) | 3.04 (0.84) | 3.02 (1.01) |
|
|
Missing | 4 | 8 | 3 | 7 |
aSD: standard deviation.
bHBA1c: glycated hemoglobin.
cBMI: body mass index.
dS-cholesterol: serum cholesterol.
eHDL: high-density lipoprotein.
fLDL: low-density lipoprotein.